ARCHIVES

Immune Therapy Possible For Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Rare Lung Disease Raises Risk Of Meningiomas

October 26, 2001

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

USC, Wisconsin Get Construction Grants Totaling $1.5 Million

March 23, 1990

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994